Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Dec;16(6):718–721. doi: 10.1111/j.1365-2125.1983.tb02248.x

The effect of selective and non-selective beta-adrenoceptor blockade, and of naloxone infusion, on the hormonal mechanisms of recovery from insulin-induced hypoglycaemia in man.

J G Armitstead, S L Lightman, M J Brown, R C Causon, N J Vaughan
PMCID: PMC1428331  PMID: 6140940

Abstract

The rise in plasma adenosine-3',5'-monophosphate occurring in response to insulin induced hypoglycaemia in normal human subjects, was abolished by non-selective beta-adrenoceptor blockade but unaffected by selective beta 1-adrenoceptor blockade. This implies that the rise is secondary to beta 2-adrenoceptor stimulation. The abolition of this rise by non-selective beta-adrenoceptor blockade had no pronounced effect on the recovery from hypoglycaemia. Endogenous opiate receptor blockade with naloxone had no significant effect on the recovery from insulin induced hypoglycaemia, or the hormonal mechanisms involved.

Full text

PDF
720

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alford F. P., Bloodm S. R., Nabarro J. D. Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay. Diabetologia. 1977 Jan;13(1):1–6. doi: 10.1007/BF00996319. [DOI] [PubMed] [Google Scholar]
  2. Brown B. L., Albano J. D., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971 Feb;121(3):561–562. doi: 10.1042/bj1210561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown M. J., Allison D. J., Jenner D. A., Lewis P. J., Dollery C. T. Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet. 1981 Jan 24;1(8213):174–177. doi: 10.1016/s0140-6736(81)90058-1. [DOI] [PubMed] [Google Scholar]
  4. Bruni J. F., Watkins W. B., Yen S. S. beta-Endorphin in the human pancreas. J Clin Endocrinol Metab. 1979 Oct;49(4):649–651. doi: 10.1210/jcem-49-4-649. [DOI] [PubMed] [Google Scholar]
  5. Cryer P. E. Glucose counterregulation in man. Diabetes. 1981 Mar;30(3):261–264. doi: 10.2337/diab.30.3.261. [DOI] [PubMed] [Google Scholar]
  6. Davidson N. M., Corrall R. J., Shaw T. R., French E. B. Observations in man of hypoglycaemia during selective and non-selective beta-blockade. Scott Med J. 1977 Jan;22(1):69–72. doi: 10.1177/003693307702200117. [DOI] [PubMed] [Google Scholar]
  7. Deacon S. P., Barnett D. Comparison of atenolol and propranolol during insulin-induced hypoglycaemia. Br Med J. 1976 Jul 31;2(6030):272–273. doi: 10.1136/bmj.2.6030.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hamet P., Lowder S. C., Hardman J. G., Liddle G. W. Effect of hypoglycemia on extracellular levels of cyclic AMP in man. Metabolism. 1975 Oct;24(10):1139–1144. doi: 10.1016/0026-0495(75)90150-x. [DOI] [PubMed] [Google Scholar]
  9. Lager I., Blohmé G., Smith U. Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics. Lancet. 1979 Mar 3;1(8114):458–462. doi: 10.1016/s0140-6736(79)90821-3. [DOI] [PubMed] [Google Scholar]
  10. Liljenquist J. E., Bomboy J. D., Lewis S. B., Sinclair-Smith B. C., Felts P. W., Lacy W. W., Crofford O. B., Liddle G. W. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men. J Clin Invest. 1974 Jan;53(1):198–204. doi: 10.1172/JCI107538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lloyd-Mostyn R. H., Oram S. Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet. 1975 May 31;1(7918):1213–1215. doi: 10.1016/s0140-6736(75)92195-9. [DOI] [PubMed] [Google Scholar]
  12. McMurtry R. J. Letter: Propranolol, hypoglycemia, and hypertensive crisis. Ann Intern Med. 1974 May;80(5):669–670. doi: 10.7326/0003-4819-80-5-669. [DOI] [PubMed] [Google Scholar]
  13. Newman R. J. Comparison of propranolol, metoprolol, and acebutolol on insulin-induced hypoglycaemia. Br Med J. 1976 Aug 21;2(6033):447–449. doi: 10.1136/bmj.2.6033.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pecker F., Duvaldestin P., Berthelot P., Hanoune J. The adenylate cyclase system in human liver: characterization, subcellular distribution and hormonal sensitivity in normal or cirrhotic adult, and in foetal liver. Clin Sci (Lond) 1979 Oct;57(4):313–325. doi: 10.1042/cs0570313. [DOI] [PubMed] [Google Scholar]
  15. Reid R. L., Yen S. S. beta-Endorphin stimulates the secretion of insulin and glucagon in humans. J Clin Endocrinol Metab. 1981 Mar;52(3):592–594. doi: 10.1210/jcem-52-3-592. [DOI] [PubMed] [Google Scholar]
  16. Strange R. C., Mjos O. D. The sources of plasma cyclic AMP: studies in the rat using isoprenaline, nicotinic acid and glucagon. Eur J Clin Invest. 1975 Apr;5(2):147–152. doi: 10.1111/j.1365-2362.1975.tb00440.x. [DOI] [PubMed] [Google Scholar]
  17. Van Loon G. R., Appel N. M., Ho D. beta-Endorphin-induced stimulation of central sympathetic outflow: beta-endorphin increases plasma concentrations of epinephrine, norepinephrine, and dopamine in rats. Endocrinology. 1981 Jul;109(1):46–53. doi: 10.1210/endo-109-1-46. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES